Replimune Group
REPL
REPL
141 hedge funds and large institutions have $1.27B invested in Replimune Group in 2023 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 45 increasing their positions, 59 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0.48% less ownership
Funds ownership: 94.98% → 94.5% (-0.48%)
24% less repeat investments, than reductions
Existing positions increased: 45 | Existing positions reduced: 59
34% less call options, than puts
Call options by funds: $9.34M | Put options by funds: $14.2M
Holders
141
Holding in Top 10
4
Calls
$9.34M
Puts
$14.2M
Top Buyers
| 1 | +$24.1M | |
| 2 | +$14.1M | |
| 3 | +$13.6M | |
| 4 |
B
Braidwell
Stamford,
Connecticut
|
+$9.61M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$9.08M |
Top Sellers
| 1 | -$18.9M | |
| 2 | -$12.2M | |
| 3 | -$11.7M | |
| 4 |
FLSM
Frazier Life Sciences Management
Palo Alto,
California
|
-$6.97M |
| 5 |
Morgan Stanley
New York
|
-$4.55M |